Until every
disease is cured.

We're building AI agents to help discover and develop new medicines.

Explore the platform Our approach
A molecule approaches a protein, settles into its binding pocket, then withdraws. This is an illustration. Drag to rotate the scene, or drag horizontally on a touch screen; swipe vertically to scroll. With the scene focused, use arrow keys to turn, plus and minus to zoom, Home to reset, and Space to pause or play.

An AI Agent for Drug Discovery

AgentCures connects the steps of drug discovery. Our AI agent reviews research, designs molecules, suggests experiments, and drafts regulatory documents. Scientists can review its work and guide the next steps. What is an AI agent?

Drug Cards

Pharma as Code

We keep experiments, molecular data, and regulatory drafts structured and version-controlled. AgentCures records its work in Git so the team can see what changed, review the evidence, and return to earlier versions. What is version control and Git?

Scientists and AI, Working Together

Scientists and engineers bring the judgment that research needs. They use the same version control system as the AI agent to review proposals, challenge assumptions, and add new findings to the shared research record.

Assay Protocols in Git

Research That Stays Up to Date

As new results arrive, the agent updates its analyses and research plans. It also drafts papers, regulatory documents, and articles for this website, keeping the writing connected to the work behind it.

Planning Clinical Trials

The platform uses patient groups and models of how a drug behaves in the body to draft trial protocols. Teams can compare study designs, simulated outcomes, and the assumptions behind them before enrolling patients.

More Time for the Science

We automate the work that slows research down: running computational analyses, comparing candidates, planning assays, and preparing drafts. The goal is to give scientists more time to investigate promising ideas and decide which ones deserve the next experiment.

An illustrated sweep of small molecules highlights a promising candidate.

Founded by JJ Ben-Joseph

JJ Ben-Joseph

JJ Ben-Joseph works at the intersection of biology, AI, and security. His background spans research, venture investing, product development, and founding companies. Johns Hopkins University named him an "Emerging Leader in Biosecurity." Learn more on his LinkedIn profile.